天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

TargetMol中國（陶術生物） Company Information
Company Name:    TargetMol Chemicals Inc.
Tel:    -
Email:    marketing@targetmol.cn
Nationality:    China
WebSite:    https://www.targetmol.cn/
Product List:    26727
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179
Product List
LabMol-319 381188-63-2
Fadrozole HCl hydrate 176702-70-8
Minamestane 105051-87-4
Vinaxanthone 133293-89-7
UCB7362 2610631-17-7
Annamycin 92689-49-1
Ciproquazone 33453-23-5
Safironil 134377-69-8
ALDH2 modulator 1 1629615-99-1
Pipoxizine 55837-21-3
Elbanizine 110629-41-9
Pafenolol 75949-61-0
Tiflucarbine 89875-86-5
Tampramine 83166-17-0
Rociclovir PM 89419-23-8
Inaperisone 99323-21-4
MK-6186 1034474-19-5
Losulazine 72141-57-2
(Rac)-Norcisapride 84946-16-7
Ontazolast 147432-77-7
Solpecainol 155321-96-3
Saterinone 102669-89-6
Tazomeline 131987-54-7
GS-6620 PM 1191237-49-6
Camonagrel 105920-77-2
Oxepinac 55689-65-1
(16aR)-1,16-Bis(diphenylphosphino)-6,7,8,9,10,11-hexahydrodibenzo[b,d][1,6]dioxacyclododecine 301847-92-7
CSF1R-IN-3 2760584-90-3
HAMI 3379 1245653-57-9
Efpeglenatide 1296200-77-5
Laniquidar 197509-46-9
Regorafenib mesylate 835621-08-4
PI3K/mTOR Inhibitor-4 2361215-32-7
ABC44 1831135-46-6
PND-1186 hydrochloride 1356154-94-3
Bafrekalant 2256770-44-0
PTP1B-IN-15 765317-71-3
Methyl 3-(3-bromophenyl)-1,2-oxazole-5-carboxylate 377059-68-2
(15aS)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine 486429-95-2
Clevudine triphosphate 174625-00-4
MCT1-IN-3 2878360-80-4
(15aR)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine 301847-91-6
4,4'-(Triaz-1-ene-1,3-diyl)dibenzimidamide hydrochloride 2331268-15-4
BSJ-01-175 2227392-55-2
BTA-188 314062-80-1
UCM-1306 2258608-78-3
Vamotinib 1416241-23-0
Nezulcitinib 2412496-23-0
CQ211 2648986-65-4
Mytoxin B 105049-15-8
ONO-9780307 856691-44-6
Glucametacine 52443-21-7
Org 43553 501444-88-8
Duocarmycin analog-2 1164275-01-7
DG013A 2007955-07-7
CCT369260 2647503-57-7
UNC4203 1818234-19-3
GSK2647544 1380426-95-8
RIPK3-IN-1 2361139-70-8
NF-κB/MAPK-IN-1 2413940-56-2
ITK inhibitor 6 2404604-06-2
Tubulin inhibitor 23 170488-57-0
BMS-566419 566161-24-8
SMO-IN-3 2376914-71-3
CDK5-IN-2 2639542-22-4
GNF2133 hydrochloride 2561414-57-9
Tau-aggregation and neuroinflammation-IN-1 2175953-98-5
Xanthine amine congener hydrochloride 1783977-95-6
NDB 1660153-08-1
Ezurpimtrostat hydrochloride 1914148-73-4
TXA6101 1459695-66-9
CJ-2360 2226742-61-4
Nrf2 activator-4 2383016-68-8
10-Formyl-5,8-dideazafolic acid 61038-31-1
IXA6 1021106-40-0
BS-181 dihydrochloride 1883548-83-1
A2A receptor antagonist 3 2738606-83-0
Tripelennamine citrate 6138-56-3
BRL-15572 hydrochloride 1173022-77-9
Glyoxalase I inhibitor 2 2314467-61-1
Darglitazone Sodium 149904-87-0
ZINC09659342 1668604-47-4
MK-8153 1548286-45-8
18-Deoxyherboxidiene 1200128-66-0
Edecesertib 2408839-73-4
DDO-02005 1186049-44-4
Paltimatrectinib 2353522-15-1
ST247 1356497-91-0
SARS-CoV-2 nsp13-IN-1 1005304-44-8
Epitinib 1203902-67-3
BI-10 2759037-58-4
Sovesudil 1333400-14-8
HTT-D3 2254502-89-9
Penamecillin 983-85-7
ML138 1355243-24-1
Quinine hydrobromide 549-49-5
EHT 5372 1425945-63-6
CB1R antagonist 1 334668-69-8
HIV-1 inhibitor-31 920036-04-0
BACE-IN-1 1254166-60-3
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179
Copyright 2007©  ChemicalBook. All rights reserved.